Results 241 to 250 of about 1,215,177 (361)

Multiplex single‐cell profiling of putative cancer stem cell markers ALDH1, SOX9, SOX2, CD44, CD133 and CD15 in endometrial cancer

Molecular Oncology, EarlyView.
Cancer stem cells are associated with aggressive disease, but a deep characterization of such markers is lacking in endometrial cancer. This study uses imaging mass cytometry to explore putative cancer stem cell markers in endometrial tumors and corresponding organoid models.
Hilde E. Lien, Marta E. Hjelmeland, Hege F. Berg, Rose M. Gold, Kathrine Woie, Lars A. Akslen, Ingfrid S. Haldorsen, Camilla Krakstad   +7 more
wiley   +1 more source

Correction to: Deciphering the generation of heterogeneity in esophageal squamous cell carcinoma metastasis via singlecell multiomics analysis. [PDF]

J Transl Med
Sheng K, Chen J, Xu R, Sun H, Liu R, Wang Y, Xu W, Guo J, Zhang M, Liu S, Lei J, Sun Y, Jia Y, Guo D.   +13 more
europepmc   +1 more source

THE BIOCHEMISTRY OF THE METABOLIC FECAL PROTEIN NITROGEN

, 1948
Anthony A. Albanese, Virginia I. Davis, Marilyn Lein, Emilie M. Smetak   +3 more
openalex   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Corrigendum to: Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers. [PDF]

Biochem Med (Zagreb)
Begolli G, Lukić M, Rumora L, Čorak L, Vukić Dugac A, Jakopović M, Samaržija M, Tomaš I, Knežević J, Debeljak Ž.   +9 more
europepmc   +1 more source

Textbook of Biochemistry

, 1943
NULL AUTHOR_ID
openalex   +1 more source

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Corrigendum: Antioxidant, Anti-Alzheimer's, anticancer, and cytotoxic properties of peanut oil: <i>in vitro</i>, <i>in silico</i>, and GC-MS analysis. [PDF]

Front Chem
Djeghim H, Benouchenne D, Mokrani EH, Alsaeedi H, Cornu D, Bechelany M, Barhoum A.   +6 more
europepmc   +1 more source

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma

Molecular Oncology, EarlyView.
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh, Amelia Martinez Villarreal, Philippe Lefrançois, Jennifer Gantchev, Sriraam Sivachandran, Samy Abou Setah, Ivan V. Litvinov   +6 more
wiley   +1 more source

Correction: Metabolomic heterogeneity of ageing with ethnic diversity: a step closer to healthy ageing. [PDF]

Metabolomics
Trivedi D, Hollywood KA, Xu Y, Wu FCW, Trivedi DK, Goodacre R.   +5 more
europepmc   +1 more source